The recent outbreaks of Marburg virus in Equatorial Guinea and Tanzania raises once more the specter of pandemic potential pathogens of a highly deadly nature for which the world is woefully unprepared.
The story of how this vaccine was designed, developed and licensed at breathtaking speed - in under a year - by the labs of Oxford University has become scientific legend.
To facilitate its drive to scale-up manufacturing of infectious disease reagents, antibodies and assays since moving to new premises opened by parent company LGC Clinical Diagnostics, The Native Antigen Company announced the key appointments of Richard White, Business Development Manager and Pardeep Sharda, Senior Product Manager. Click to read more.